SCHEMBL3569883

SCHEMBL3569883

O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCC(OCCN1CCCC1)c1ccccc1-3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.47
MMP12 P39900 1/20 0.47
SCN9A Q15858 1/20 0.41
KDM4E B2RXH2 6/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 4/20 0.37
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
NR1I2 O75469 2/20 0.36
HRH3 Q9Y5N1 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LTA4H P09960 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3092706 0.97 PRKCA (0.46) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL4912399 0.88 KCNH2 (0.45) PRKCAMMP12SCN9AESR1ESR2
SCHEMBL4918237 0.87 PRKCA (0.58) PRKCAMMP12SCN9ANR1I2CYP3A4
SCHEMBL4919446 0.86 PRKCA (0.51) PRKCAMMP12SCN9ALMNANR1I2
SCHEMBL3080110 0.86 PRKCA (0.45) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL3575065 0.86 SCN9A (0.39) PRKCAMMP12SCN9AALDH1A1ESR1
SCHEMBL3574133 0.84 PRKCA (0.47) PRKCAMMP12SCN9ANR1I2CYP3A4
SCHEMBL3568763 0.84 PRKCA (0.56) PRKCAMMP12SCN9ANR1I2HRH3
SCHEMBL3567161 0.82 PRKCA (0.49) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL2156486 0.82 KDM4E (0.37) KDM4ESMN1; SMN2ALDH1A1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US claimed
US-7662809-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-02-16 US disclosed
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, HAVCR2 PRKCA 4232/4885MMP12 2495/4885SCN9A 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.